Identification of the anticancer effects of a novel proteasome inhibitor, ixazomib, on colorectal cancer using a combined method of microarray and bioinformatics analysis

PURPOSE: The study aimed to explore the anticancer effects of a novel proteasome inhibitor, ixazomib, on colorectal cancer (CRC) using a combined method of microarray and bioinformatics analysis. MATERIALS AND METHODS: Cell proliferation was tested by Cell Counting Kit-8 (CCK-8) assay for SW620 cell...

Descripción completa

Detalles Bibliográficos
Autores principales: Fan, Qiaowei, Liu, Bingrong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5530849/
https://www.ncbi.nlm.nih.gov/pubmed/28790851
http://dx.doi.org/10.2147/OTT.S139686

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5530849/
https://www.ncbi.nlm.nih.gov/pubmed/28790851
http://dx.doi.org/10.2147/OTT.S139686

Ejemplares similares